Sentences with phrase «for life sciences firms»

Not exact matches

• Altitude Life Science Ventures, a Seattle - based venture capital firm, is seeking to raise $ 125 million for its third fund, according to an SEC filing.

There actually isn't a lack of interest, on the financial side, in fueling Alzheimer's research given the critical need for it and the rewards that life sciences firms would reap from even a modestly - successful product.

Raymond James's Bapty says CROs represent a huge growth area for Canada's life sciences firms.

About half of the company's $ 2.7 million in revenue comes from the federal government, with law, marketing research, and life sciences firms responsible for the rest.

Before joining Icon, Taki was the VP of Investor Relations for SB Life Science, a healthcare - focused venture capital firm sponsored by Softbank Corporation.

Mike is a serial entrepreneur with almost two decades of experience developing large - scale databases and predictive algorithms for digital media, financial and life sciences firms.

If your work involves life sciences dealmaking, you know it's the time of year to start firming up your plans for the week of the J.P. Morgan Healthcare Conference.

(He's scheduled to depart later in the day for he west coast where he will raise campaign cash, meet with life sciences firms in Seattle, WA, discuss immigration with the mayor of Sacramento and meet tech industry leaders in San Francisco, CA).

He set up a commercial entity - Global Science Research - and later developed the personality quiz My Digital Life for SCL, using a market research firm to recruit 200,000 people to take part.

Brum remained at Biogen for 3 years, completed a 1 - year MBA at Simmons College, and then joined Feinstein Kean Partners, a Cambridge PR firm that focuses on life science start - ups.

The new advisors, some of the most wellrespected individuals in their fields, were specifically sought for the wealth of experience they bring to bear on Foundation efforts to advance drug development in SMA: Paul S. Anderson, PhD, retired vice president for Chemistry at Merck, G. Stephen DeCherney, MD, MPH, president of Clinical Development Services Americas for Quintiles Transnational Corp., Corey S. Goodman, PhD, president and chief executive officer of Renovis, Inc., Jonathan S. Leff, managing director at Warburg Pincus LLC and responsible for the firm's life sciences investment effort, John H. Park, Partner at Blum Capital Partners, LP, and Wesley Thompson, PhD, professor of Neurobiology at The University of Texas at Austin.

After Tularik she worked for larger biotechnology companies like Genentech and a life science focused Executive Search Firm.

She later worked for larger biotechnology companies like Genentech and for a life science focused Executive Search Firm.

Don Ware, chair of the firm's Intellectual Property Department, was ranked in Tier 1 of the individual patent litigators in Massachusetts and was noted for his «fantastic reputation as a life sciences specialist.»

«He has a unique strength in counseling emerging growth companies, including in the life sciences industry, which is an expanding practice for the firm.»

We have great relationships with firms in Boston in life sciences, for example.

Silicon Valley - based firm Cooley landed the London office of the year award as it continues to carve out a reputation as the go - to practice for tech and life sciences in the City.

«The pharmaceutical, life sciences and technology markets in New Jersey, New York and Pennsylvania are strategic priorities for the firm, and the additions of Andrew and Michael bolster the firm's capabilities to address the constantly increasing needs of clients in these sectors.»

As counsel in the Firm's Intellectual Property and Life Sciences Practice Groups, John Rearick, PhD will continue to focus his practice on crafting strategic IP protection in the life science and chemical landscapes, as well as positioning clients» technology for licensing and partnering opportunitLife Sciences Practice Groups, John Rearick, PhD will continue to focus his practice on crafting strategic IP protection in the life science and chemical landscapes, as well as positioning clients» technology for licensing and partnering opportunitlife science and chemical landscapes, as well as positioning clients» technology for licensing and partnering opportunities.

We are the firm of choice for many multinationals and private equity firms seeking M&A opportunities in the country, particularly in the burgeoning tech, pharma and life - sciences sectors.

The Canadian firm's life sciences and pharmaceuticals group will spawn a sixth global sector focus across the Norton Rose network, he says, though Ogilvy doesn't have an office in Vancouver, a key centre for the industry in Canada.

10.30 am Our next session sees CMS senior partner Penelope Warne, Eversheds Sutherland co-CEO Lee Ranson, Santa Fe general counsel Janet McCarthy and Fieldfisher life sciences and healthcare head Alison Dennis join Hogan Lovells London managing partner Susan Bright for a discussion on law firm diversity and inclusion efforts.

The US firm is planning to launch a life sciences and technology practice in the Irish Republic, but is currently waiting for regulatory clearance from the Irish Law Society.

For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe, providing the industry experience and analytical expertise needed to solve their most challenging strategic problems and resolve their most contentious disputes.

Successfully advocating for life sciences industry clients in high - profile litigation matters, we have one of the most experienced Class Actions teams in Canada and are among a small number of Canadian firms with notable success at trial and on dispositive applications and motions.

As counsel in the firm's Intellectual Property Group, Robert Sahr, Ph.D., will continue to focus his practice on advising and assisting clients in obtaining global patent protection for inventions in the life sciences, in particular therapeutic and diagnostic products.

Law firm Stephenson Harwood LLP has advised a new client, AIM - listed life sciences company TyraTech Inc. on the shareholder consent required for the US$ 17.5 million sa..

The Index identifies the most active and relevant law firms for life science companies.

ACCOMPLISHMENTS * Launched the Digital Customer Experience Practice for a $ 1B IT Services firm with focused solutions in insurance, life sciences, banking, and manufacturing vertical markets.